Income Before Tax

Pre-Tax Income

Merck & Co. Pre-Tax Income decreased by 203.3% to -$3.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 159.9%, from $5.90B to -$3.53B. Over 3 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 14.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.

Detailed definition

A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...

Peer comparison

Used to compare companies across different tax jurisdictions to see who generates more raw profit.

Metric ID: income_before_tax

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.72B$5.27B$3.43B$4.86B$4.49B$3.58B$3.51B$3.65B-$5.34B$5.62B$5.67B$6.01B$4.09B$4.17B$5.90B$5.00B$6.75B$3.42B-$3.53B
QoQ Change+206.7%-34.8%+41.6%-7.7%-20.1%-2.0%+3.9%-246.2%+205.3%+0.9%+5.9%-31.9%+2.0%+41.6%-15.3%+34.9%-49.3%-203.3%
YoY Change+161.3%-32.0%+2.3%-24.9%-218.9%+56.9%+55.3%+212.6%-27.2%+4.1%-16.8%+64.9%-18.0%-159.9%
Range-$5.34B$6.75B
CAGR+17.4%
Avg YoY Growth+4.3%
Median YoY Growth-7.2%
Current Streak2 quarters decline

Business Segments

View all
SegmentQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Pharmaceutical$11.20B$11.55B$10.88B$10.71B$11.01B$12.54B$11.49B$11.52B
Animal Health$508.00M$510.00M$365.00M$634.00M$593.00M$511.00M$393.00M$722.00M
Total$6.01B$4.09B$4.17B$5.90B$5.00B$6.75B$3.42B-$3.53B

Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Merck & Co.'s pre-tax income?
Merck & Co. (MRK) reported pre-tax income of -$3.53B in Q1 2026.
How has Merck & Co.'s pre-tax income changed year-over-year?
Merck & Co.'s pre-tax income decreased by 159.9% year-over-year, from $5.90B to -$3.53B.
What is the long-term trend for Merck & Co.'s pre-tax income?
Over 3 years (2021 to 2025), Merck & Co.'s pre-tax income has grown at a 14.9% compound annual growth rate (CAGR), from $13.88B to $21.07B.
What does pre-tax income mean?
The total profit a company made before paying its income taxes.